OPC Pharmaceutical JSC (HOSE: OPC)

OPC Pharmaceutical JSC Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	982,733	1,004,887	1,171,614	1,123,728	965,591	989,390
Revenue Growth (YoY)	-5.44%	-14.23%	4.26%	16.38%	-2.41%	-1.31%
Cost of Revenue	502,471	526,456	637,906	643,499	572,130	554,032
Gross Profit	480,263	478,431	533,708	480,229	393,460	435,358
Selling, General & Admin	340,429	332,311	355,073	313,516	257,049	305,675
Operating Expenses	340,429	332,311	355,073	313,516	257,049	305,675
Operating Income	139,834	146,120	178,636	166,713	136,411	129,683
Interest Expense	-	-334.55	-925.2	-4,819	-5,490	-7,520
Interest & Investment Income	8,373	15,854	7,813	3,707	4,391	4,345
Earnings From Equity Investments	1,414	838.45	797.74	172.88	1,877	209.96
Currency Exchange Gain (Loss)	577.99	555.41	279.37	360.84	622.41	-148.51
Other Non Operating Income (Expenses)	-8,697	-7,710	-6,677	-6,894	-5,034	-5,271
EBT Excluding Unusual Items	141,502	155,323	179,924	159,241	132,778	121,299
Gain (Loss) on Sale of Assets	-	-	-	-	-	9,885
Pretax Income	141,502	155,323	179,924	159,241	132,778	131,183
Income Tax Expense	29,937	33,004	37,530	35,878	29,871	29,935
Earnings From Continuing Operations	111,565	122,319	142,394	123,363	102,907	101,249
Minority Interest in Earnings	-1,324	-84.74	-266.22	3,014	2,884	-317.88
Net Income	110,240	122,234	142,128	126,377	105,791	100,931
Preferred Dividends & Other Adjustments	16,041	17,543	14,010	13,416	10,993	10,539
Net Income to Common	94,199	104,691	128,118	112,961	94,798	90,392
Net Income Growth	-20.78%	-14.00%	12.46%	19.46%	4.82%	2.84%
Shares Outstanding (Basic)	64	64	64	64	64	64
Shares Outstanding (Diluted)	64	64	64	64	64	64
Shares Change (YoY)	-	-	-	-0.00%	-	3.04%
EPS (Basic)	1470.69	1634.49	2000.25	1763.61	1480.03	1411.24
EPS (Diluted)	1470.00	1634.00	2000.00	1763.61	1480.03	1411.20
EPS Growth	-25.32%	-18.30%	13.40%	19.16%	4.88%	-0.32%
Free Cash Flow	70,179	243,317	28,688	181,809	93,340	28,997
Free Cash Flow Per Share	1095.68	3798.80	447.90	2838.51	1457.26	452.72
Dividend Per Share	1500.000	1500.000	1500.000	-	1244.813	1244.813
Dividend Growth	0%	0%	-	-	0%	50.00%
Gross Margin	48.87%	47.61%	45.55%	42.74%	40.75%	44.00%
Operating Margin	14.23%	14.54%	15.25%	14.84%	14.13%	13.11%
Profit Margin	9.59%	10.42%	10.94%	10.05%	9.82%	9.14%
Free Cash Flow Margin	7.14%	24.21%	2.45%	16.18%	9.67%	2.93%
EBITDA	162,252	169,015	201,454	189,215	158,152	155,184
EBITDA Margin	16.51%	16.82%	17.19%	16.84%	16.38%	15.68%
D&A For EBITDA	22,418	22,895	22,819	22,502	21,740	25,501
EBIT	139,834	146,120	178,636	166,713	136,411	129,683
EBIT Margin	14.23%	14.54%	15.25%	14.84%	14.13%	13.11%
Effective Tax Rate	21.16%	21.25%	20.86%	22.53%	22.50%	22.82%
Revenue as Reported	982,733	1,004,887	1,171,614	1,123,728	965,591	989,390
Advertising Expenses	-	51,343	48,858	40,148	17,880	18,505

Source: S&P Capital IQ. Standard template. Financial Sources.